Cardiology

A secondary analysis of a cluster RCT indicated the Texas Sprouts intervention led to improvements in glucose control and reduced LDL-C in high-risk schoolchildren.

In this case report, a man in his 50s with a history of ESRD, alcoholic cirrhosis, and anemia presents to the emergency department for evaluation of generalized weakness after missing his last 2 dialysis appointments. Check out the ECG and determine the most likely cause of the rhythm!

Applying a statistical model to estimate the effects of reducing sodium intake at a population level in Australia, investigators suggest adherence to World Health Organization benchmarks could prevent 6900 deaths from CVD, CKD, and stomach cancers annually.

Using data from 2 large prospective studies, a Harvard-led team estimates the impact of adherence to a group of healthy eating patterns on risk of all-cause and cause-specific mortality.

The COACH trial reported a hospital-based strategy led to lower risk of death from any cause or hospitalization for cardiovascular causes within 30 days than usual care in patients with acute heart failure.

Patients with AF experienced worse 90-day outcomes than those without AF, even with comparable, successful reperfusion outcomes.

Data from a 2019 survey of more than 5000 cardiologists across the globe suggests 28% of the field may be experiencing some form of mental health condition, with results also shedding light on predictors of mental health conditions.

Using data from more than 55,000 people with diabetes using metformin is providing new insight into the apparent reductions in risk of negative cardiovascular and renal outcomes as well as all-cause mortality with use of SGLT2 inhibitors.

Ulcerative colitis was considered an independent risk factor, while Crohn’s disease and unclassified inflammatory bowel disease were not.

Using real-world data from the US, Japan, and Sweden provides insight into contemporary trends in GDMT use, including initiation, uptitration, and discontinuation, following hospitalization among patients with heart failure with reduced ejection fraction.

Michael J. Ackerman, MD, PhD, discusses the simplicity and availability of education around CPR and defibrillator use, and the role of clinicians in raising public health preparedness.

A Mayo Clinic cardiologist discusses the national variability in CPR and AED access, and the actions that saved Hamlin's life during Monday Night Football.

Jesse Morse, MD, a sports medicine specialist, discusses commotio cordis and how to effectively communicate with athletes and parents of young athletes about the diagnosis in the wake of an incident where a player collapsed during a recent NFL game.

This cardiology case report from Brady Pregerson, MD, features a patient in their early 70s presenting to the hospital with reports of shortness of breath, palpitations, and chest pain. Can you determine the correct diagnosis?

To celebrate the end of 2022 and the advances witnessed in the past year, our editorial team has created a list of the 5 most popular pieces of content related to endocrinology from 2022.

From a topical gene therapy to a debated heart failure option, a litany of unique agents are anticipated for FDA decision in the new year.

Our editorial team is celebrating the end of 2022 by recapping our most popular content from the 3 largest cardiology meetings from the past year.

With less than a week to go until the close of 2022, our editorial team is celebrating the final week of the year by recapping some of our most popular stories and content from the past year. Here, we are highlighting our most popular episodes of the Don’t Miss a Beat Podcast from 2022.

For the final week of the year, our editorial team is recapping our the most talked about phase 3 trial news, approvals, and CRLs related to cardiometabolic health in 2022, including empagliflozin, bempedoic acid, mavacamten, and more!

Our editorial team is kicking off the final week of the year by recapping our most popular case reports from Brady Pregerson, MD, from the past year.

The December 2022 cardiology month in review features the announcement of CLEAR Outcomes meeting its primary end point, a pair of new scientific statements from the American Heart Association, and more!

As physician demands continue to climb in the high-demand specialty, patient-reported outcomes have emerged as a viable tool in assessment and care.

An observational study of data from patients with cancer treated with immune checkpoint inhibitors provides an overview of prognostic utility of noncardiac biomarkers for predicting myocarditis and all-cause mortality.

On December 16, the world's foremost cardiology organizations released a joint opinion statement calling for a reinvention of clinical trials to better suit the needs of the healthcare system in the 21st century.